Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Lutomski

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Pharmacotherapy|December 17, 1998
Warfarin, short bowel syndrome, and intravenous lipidsD M Lutomski
JPEN. Journal of Parenteral and Enteral Nutrition|March 1, 1989
Warfarin resistance and enteral feedingsJ E Martin, D M Lutomski
Clinical Pharmacy|May 1, 1984
Co-trimoxazole use for resistant Pseudomonas maltophiliaJ O Rivera, D M Lutomski
The American Journal of the Medical Sciences|April 1, 1994
The effect of thrombocytosis on serum potassium and phosphorus concentrationsD M Lutomski, R H Bower
Clinical Pharmacokinetics|January 1, 1995
Pharmacokinetic optimisation of the treatment of embolic disordersD M Lutomski, M Bottorff, K Sangha
JPEN. Journal of Parenteral and Enteral Nutrition|May 1, 1987
Warfarin resistance associated with intravenous lipid administrationD M Lutomski, J E Palascak, R H Bower
Archives of Internal Medicine|March 1, 1987
Warfarin therapy. The effect of heparin on prothrombin timesD M Lutomski, P E Djuric, R W Draeger
American Journal of Hospital Pharmacy|November 1, 1985
Automated administration of intermittent intravenous dosesD M Lutomski, J Schwartz-Fulton, J O Rivera
Clinical Pharmacy|August 1, 1993
Accuracy of a first-order model for estimating initial heparin dosageL E Joch, D M Lutomski, D J Williams, et al.
The Annals of Pharmacotherapy|March 1, 1993
Sorbitol content of selected oral liquidsD M Lutomski, M L Gora, S M Wright, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Pharmacotherapy|December 17, 1998
Warfarin, short bowel syndrome, and intravenous lipidsD M Lutomski
JPEN. Journal of Parenteral and Enteral Nutrition|March 1, 1989
Warfarin resistance and enteral feedingsJ E Martin, D M Lutomski
Clinical Pharmacy|May 1, 1984
Co-trimoxazole use for resistant Pseudomonas maltophiliaJ O Rivera, D M Lutomski
The American Journal of the Medical Sciences|April 1, 1994
The effect of thrombocytosis on serum potassium and phosphorus concentrationsD M Lutomski, R H Bower
Clinical Pharmacokinetics|January 1, 1995
Pharmacokinetic optimisation of the treatment of embolic disordersD M Lutomski, M Bottorff, K Sangha
JPEN. Journal of Parenteral and Enteral Nutrition|May 1, 1987
Warfarin resistance associated with intravenous lipid administrationD M Lutomski, J E Palascak, R H Bower
Archives of Internal Medicine|March 1, 1987
Warfarin therapy. The effect of heparin on prothrombin timesD M Lutomski, P E Djuric, R W Draeger
American Journal of Hospital Pharmacy|November 1, 1985
Automated administration of intermittent intravenous dosesD M Lutomski, J Schwartz-Fulton, J O Rivera
Clinical Pharmacy|August 1, 1993
Accuracy of a first-order model for estimating initial heparin dosageL E Joch, D M Lutomski, D J Williams, et al.
The Annals of Pharmacotherapy|March 1, 1993
Sorbitol content of selected oral liquidsD M Lutomski, M L Gora, S M Wright, et al.
Pageof 2